Who was Barbara Mitchell?
  1. access to new drugs
  2. access to new drugs

access to new drugs

Février 21, 2019 10:03AM

Trudeau government's drug-pricing plan may limit access to new life-improving medicines
Bacchus Barua, Steven Globerman
Printer-friendly version
Trudeau government's drug-pricing plan may limit access to new life-improving medicines

Developing and testing new drugs costs a lot of money.

Étiquettes:
drug price controls, access to new drugs, access to new medicine, new prescription drugs, new drug regulations
Janvier 24, 2019 1:00AM

Pharmaceutical Regulation, Innovation, and Access to New Drugs: An International Perspective
Steven Globerman, Bacchus Barua
Printer-friendly version
Pharmaceutical Regulation, Innovation, and Access to New Drugs: An International Perspective
Étiquettes:
pharmaceutical regulations, access to new drugs, pharmaceutical innovation, pmprb, access to new medicine, reference pricing
Septembre 17, 2018 10:43AM

Ottawa's planned changes to review process will limit patient access to lifesaving drugs
Kristina M.L. Acri, née Lybecker
Printer-friendly version
Ottawa's planned changes to review process will limit patient access to lifesaving drugs

Profit incentivizes innovation and helps fund research and development.

Étiquettes:
patented medicine, patented prescription drugs, patented drugs, prescription drug patents, pharmaceutical patents, access to new drugs, access to new medicine
Août 28, 2018 1:00AM

Regulatory, Reimbursement, and Pricing Barriers to Accessing Drugs for Rare Disorders in Canada
Dr. Nigel Rawson
Printer-friendly version
Regulatory, Reimbursement, and Pricing Barriers to Accessing Drugs for Rare Disorders in Canada
Étiquettes:
drug patent laws, patented prescription drugs, access to new drugs, new drug regulations, pharmaceutical patents
Août 2, 2018 2:41PM

New pricing regulations may restrict access to innovative drugs in Canada
Bacchus Barua, Kristina M.L. Acri, née Lybecker
Printer-friendly version

Review board’s new reference countries have more limited access to new and innovative drugs.

Étiquettes:
pharmaceuticals, prescription drugs, access to new drugs, pharmaceutical innovation, patients, cancer medicine
Mars 29, 2017 3:00AM

Canadian patients suffer lack of access to cancer drugs
John R. Graham
Printer-friendly version

Under Medicare in the U.S., private insurers compete to offer coverage within regions.

Étiquettes:
patients, medical insurance, prescription drugs, access to new drugs, access to medicines, cancer drug
Janvier 4, 2017 12:00PM

Cures Act ensures U.S. will continue to outperform Canada in approving new medicines
John R. Graham
Printer-friendly version

The FDA is fundamentally reforming its drug approval process.

Étiquettes:
FDA, access to new drugs, new prescription drugs, access to health care, canadian drug approval
Juillet 17, 2014 6:00AM

Has pCODR Improved Access to Oncology Drugs?
Dr. Nigel Rawson
Printer-friendly version
Étiquettes:
pCODR, oncology drugs, pan-Canadian oncology drug review, new drug approval process, ministry of health, access to new drugs
Avril 4, 2012 2:00AM

Access Delayed, Access Denied: Waiting for New Medicines in Canada: 2012
Brett J. Skinner, Mark Rovere
Printer-friendly version
Étiquettes:
new medicine, drug approval process, new drugs, access to new drugs, FDA, health canada, drug insurance, public drug insurance
Juin 29, 2011 2:00AM

Access Delayed, Access Denied: Waiting for New Medicines in Canada 2011
Mark Rovere, Brett J. Skinner
Printer-friendly version
Étiquettes:
new medicine, drug approval process, new drugs, access to new drugs, FDA, health canada, drug insurance, public drug insurance